Pharmacokinetic model for tobramycin in acinetobacter meningitis

Annals of Pharmacotherapy

Volumn 36, Issue 1, 2002, Pages 83-86

  Chicano Piá, Pedro V ^a   Cercós Lletí, Ana Cristina ^a   Romá Sánchez, Eva ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Acinetobacter; Cerebrospinal fluid; Meningitis; Tobramycin

Indexed keywords

COLISTIN; DRUG PRESERVATIVE; SULTAMICILLIN; TOBRAMYCIN;

ACINETOBACTER; ADULT; ARTICLE; BACTERIAL MENINGITIS; BAYES THEOREM; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID ANALYSIS; COMPARTMENT MODEL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG TOLERABILITY; HUMAN; HYDROCEPHALUS; INTRACRANIAL HYPERTENSION; MALE; NONLINEAR REGRESSION ANALYSIS; PHARMACOKINETICS; PRIORITY JOURNAL;

ACINETOBACTER INFECTIONS; ADULT; ANTI-BACTERIAL AGENTS; CEREBROSPINAL FLUID SHUNTS; HUMANS; HYDROCEPHALUS; INJECTIONS, INTRAVENOUS; MALE; MENINGITIS, BACTERIAL; MODELS, BIOLOGICAL; TOBRAMYCIN;

EID: 0036143624     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.19114     Document Type: Article

References (21)

1. Antibiotic-resistant Acinetobacter meningitis in neurosurgical patients
2. Treatment of bacterial meningitis
3. Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections
4. Pharmacokinetic quantification of the exchange of drugs between blood and cerebrospinal fluid in man
5. Amikacin therapy of gram-negative bacteremia and meningitis
6. Intraventricular administration of amikacin for complicated gram-negative meningitis and ventriculitis
7. Treatment of cerebrospinal fluid leaks and gram-negative bacillary meningitis with large doses of intrathecal amikacin and systemic antibiotics
8. Intrathecal administration of amikacin for treatment of meningitis secondary to cephalosporin-resistant Escherichia coli
9. Infections in neurologic surgery. The intraventricular use of antibiotics
10. Intrathecal injections: A review of pharmaceutical factors
11. Antimicrobials: Intrathecal administration
12. Intrathecal administration of preservatives
13. Clinical response to aminoglycosides therapy. Importance of the ratio of peak concentration to minimal inhibitory concentration
14. Single or multiple daily doses of aminoglycosides: A meta-analysis
15. Effectiveness and safety of once-daily aminoglycosides: A meta-analysis
16. Once-daily aminoglycoside therapy dosing in immunocompetent adults: A meta-analysis
17. Experience with a once-daily aminoglycoside program administered to 2184 adult patients
18. Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine
19. Pharmacokinetic drug data
20. Netilmicin cerebrospinal fluid concentrations after an intravenous infusion of 400 mg in patients without meningeal inflammation